Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: An individual-level cohort study

British Journal of Cancer

Volumn 116, Issue 2, 2017, Pages 246-252

  Johns, Louise E ^a   Coleman, Derek A ^a   Swerdlow, Anthony J ^a   Moss, Susan M ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

breast cancer; evaluation; incidence based mortality; individual level; mortality; population screening

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CANCER SCREENING; CAUSE OF DEATH; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; ENGLAND; FEMALE; FOLLOW UP; HEALTH PROGRAM; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MORTALITY RATE; POPULATION; PRIORITY JOURNAL; SOCIAL STATUS; WALES; AGED; BREAST NEOPLASMS; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGY; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MORTALITY; PROCEDURES;

ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; EARLY DETECTION OF CANCER; ENGLAND; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; WALES;

EID: 85001850100     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2016.415     Document Type: Article

References (43)

1. Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, McDonald C, Muir BB, Prescott RJ, Shepherd SM (1994) The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer 70(3): 542-548.
2. Allgood PC, Warwick J, Warren RM, Day NE, Duffy SW (2008) A casecontrol study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer 98(1): 206-209.
3. Biesheuvel C, Barratt A, Howard K, Houssami N, Irwig L (2007) Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: A systematic review. Lancet Oncol 8(12): 1129-1138.
4. Blanks RG, Bennett RL, Patnick J, Cush S, Davison C, Moss SM (2005) The effect of changing from one to two views at incident (subsequent) screens in the NHS breast screening programme in England: impact on cancer detection and recall rates. Clin Radiol 60(6): 674-680.
5. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ (2000) Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ 321(7262): 665-669.
6. Bleyer A, Baines C, Miller AB (2016) Impact of screening mammography on breast cancer mortality. Int J Cancer 138(8): 2003-2012.
7. Broeders M, Moss S, Nystrom L, Njor S, Jonsson H, Paap E, Massat N, Duffy S, Lynge E, Paci E (2012) The impact of mammographic screening on breast cancer mortality in Europe: A review of observational studies. J Med Screen 19(Suppl 1): 14-25.
8. Department of Health and Welsh Office (1995) A Policy Framework for Commissioning Cancer Services. Department of Health: London, UK
9. Duffy SW, Cuzick J (2002) Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes. Appl Stat 51(2): 235-243.
10. Duffy SW, Parmar D (2013) Overdiagnosis in breast cancer screening: The importance of length of observation period and lead time. Breast Cancer Res 15(3): R41.
11. Duffy SW, Tabar L, Chen HH, Holmqvist M, Yen MF, Abdsalah S, Epstein B, Frodis E, Ljungberg E, Hedborg-Melander C, Sundbom A, Tholin M, Wiege M, Akerlund A, Wu HM, Tung TS, Chiu YH, Chiu CP, Huang CC, Smith RA, Rosen M, Stenbeck M, Holmberg L (2002) The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 95(3): 458-469.
12. Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen TH, Yen AM, Smith RA (2010) Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 17(1): 25-30.
13. Fielder HM, Warwick J, Brook D, Gower-Thomas K, Cuzick J, Monypenny I, Duffy SW (2004) A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen 11(4): 194-198.
14. Gabe R, Tryggvadottir L, Sigfusson BF, Olafsdottir GH, Sigurdsson K, Duffy SW (2007) A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol 48(9): 948-955.
15. Hakama M, Pukkala E, Soderman B, Day N (1999) Implementation of screening as a public health policy: issues in design and evaluation. J Med Screen 6(4): 209-216.
16. Health & Social Care Information Centre (2016) Breast Screening Programme, England, 2014-215. Available at www hscic gov uk.
17. Independent UK Panel on Breast Cancer Screening (2012) The benefits and harms of breast cancer screening: An independent review. Lancet 380(9855): 1778-1786.
18. Jonsson H, Nystrom L, Tornberg S, Lenner P (2001) Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. J Med Screen 8(3): 152-160.
19. Jorgensen KJ, Gotzsche PC (2010) Who evaluates public health programmes? A review of the NHS Breast Screening Programme. J R Soc Med 103(1): 14-20.
20. Jorgensen KJ, Gotzsche PC (2016) Breast cancer: Updated screening guidelines-much ado about small improvements. Nat Rev Clin Oncol 13(3): 139-140.
21. Kalager M, Zelen M, Langmark F, Adami HO (2010) Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 363(13): 1203-1210.
22. Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, Straif K (2015) Breast-cancer screening-viewpoint of the IARC Working Group. N Engl J Med 372(24): 2353-2358.
23. Massat NJ, Dibden A, Parmar D, Cuzick J, Sasieni PD, Duffy SW (2016) Impact of Screening on Breast Cancer Mortality: The UK Program 20 Years On. Cancer Epidemiol Biomarkers Prev 25(3): 455-462.
24. Michalopoulos D, Duffy SW (2016) Estimation of overdiagnosis using shortterm trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme. J Med Screen 23(4): 192-202.
25. Moritz S, Bates T, Henderson SM, Humphreys S, Michell MJ (1997) Variation in management of small invasive breast cancers detected on screening in the former south east Thames region: observational study. BMJ 315(7118): 1266-1272.
26. Moss SM, Nystrom L, Jonsson H, Paci E, Lynge E, Njor S, Broeders M (2012) The impact of mammographic screening on breast cancer mortality in Europe: A review of trend studies. J Med Screen 19(Suppl 1): 26-32.
27. Njor S, Nystrom L, Moss S, Paci E, Broeders M, Segnan N, Lynge E (2012) Breast cancer mortality in mammographic screening in Europe: A review of incidence-based mortality studies. J Med Screen 19(Suppl 1): 33-41.
28. Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen MB, Tange UB, Blichert-Toft M, Rank F, Mouridsen H, Lynge E (2005) Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 330(7485): 220.
29. Paap E, Verbeek AL, Puliti D, Paci E, Broeders MJ (2011) Breast cancer screening case-control study design: impact on breast cancer mortality. Ann Oncol 22(4): 863-869.
30. Paci E, Broeders M, Hofvind S, Puliti D, Duffy SW (2014) European breast cancer service screening outcomes: A first balance sheet of the benefits and harms. Cancer Epidemiol Biomarkers Prev 23(7): 1159-1163.
31. Paci E, Duffy SW, Giorgi D, Zappa M, Crocetti E, Vezzosi V, Bianchi S, del Turco MR (2002) Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990-96. Br J Cancer 87(1): 65-69.
32. Parvinen I, Heinavaara S, Anttila A, Helenius H, Klemi P, Pylkkanen L (2015) Mammography screening in three Finnish residential areas: comprehensive population-based study of breast cancer incidence and incidence-based mortality 1976-2009. Br J Cancer 112(5): 918-924.
33. Phillimore P, Beattie A, Townsend P (1994) Widening inequality of health in northern England, 1981-91. BMJ 308(6937): 1125-1128.
34. Puliti D, Miccinesi G, Collina N, De Lisi V, Federico M, Ferretti S, Finarelli AC, Foca F, Mangone L, Naldoni C, Petrella M, Ponti A, Segnan N, Sigona A, Zarcone M, Zorzi M, Zappa M, Paci E (2008) Effectiveness of service screening: A case-control study to assess breast cancer mortality reduction. Br J Cancer 99(3): 423-427.
35. Puliti D, Miccinesi G, Zappa M, Manneschi G, Crocetti E, Paci E (2012) Balancing harms and benefits of service mammography screening programs: A cohort study. Breast Cancer Res 14(1): R9.
36. Richardson A (2001) Screening and the number needed to treat. J Med Screen 8(3): 125-127.
37. Stockton D, Davies T, Day N, McCann J (1997) Retrospective study of reasons for improved survival in patients with breast cancer in east Anglia: earlier diagnosis or better treatment. BMJ 314(7079): 472-475.
38. Svendsen AL, Olsen AH, von Euler-Chelpin M, Lynge E (2006) Breast cancer incidence after the introduction of mammography screening: what should be expected? Cancer 106(9): 1883-1890.
39. Swedish Organised Service Screening Evaluation Group (2006) Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 15(1): 45-51.
40. Swerdlow AJ, Jones ME (2005) Tamoxifen treatment for breast cancer and risk of endometrial cancer: A case-control study. J Natl Cancer Inst 97(5): 375-384.
41. Weedon-Fekjaer H, Romundstad PR, Vatten LJ (2014) Modern mammography screening and breast cancer mortality: population study. BMJ 348: g3701.
42. Weedon-Fekjaer H, Vatten LJ, Aalen OO, Lindqvist B, Tretli S (2005) Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results. J Med Screen 12(4): 172-178.
43. Wilson RM, Evans AJ (2006) Over-diagnosis and breast cancer screening. Eur J Cancer 4(2): 6-9.